Net Cash Provided by (Used in) Operating Activities |
-21.9K |
USD |
+16.2% |
Q1 2024 |
Q1 2024 |
Net Cash Provided by (Used in) Financing Activities |
23K |
USD |
-24.5% |
Q1 2024 |
Q1 2024 |
Net Cash Provided by (Used in) Investing Activities |
0 |
USD |
|
Q1 2024 |
Q1 2024 |
Common Stock, Shares Authorized |
450M |
shares |
0% |
Q2 2024 |
Q2 2024 |
Common Stock, Shares, Issued |
15.8M |
shares |
+18.2% |
Q2 2024 |
Q2 2024 |
Common Stock, Par or Stated Value Per Share |
0 |
USD/shares |
0% |
Q2 2024 |
Q2 2024 |
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect |
-817 |
USD |
-162% |
Q1 2022 |
Q1 2022 |
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
1.69K |
USD |
-46.7% |
Q2 2024 |
Q2 2024 |
Interest Paid, Excluding Capitalized Interest, Operating Activities |
0 |
USD |
|
Q1 2024 |
Q1 2024 |
Deferred Tax Assets, Valuation Allowance |
1.58M |
USD |
+72.7% |
Q2 2024 |
Q2 2024 |
Depreciation |
0 |
USD |
-100% |
Q1 2024 |
Q1 2024 |
Deferred Tax Assets, Operating Loss Carryforwards |
1.58M |
USD |
+72.7% |
Q2 2024 |
Q2 2024 |
Preferred Stock, Shares Issued |
0 |
shares |
|
Q4 2023 |
FY 2023 |
Preferred Stock, Shares Authorized |
20M |
shares |
0% |
Q2 2024 |
Q2 2024 |
Additional Paid in Capital |
18.3M |
USD |
+43.3% |
Q2 2024 |
Q2 2024 |
Preferred Stock, Shares Outstanding |
0 |
shares |
|
Q3 2023 |
Q3 2023 |
Deferred Tax Assets, Net of Valuation Allowance |
0 |
USD |
|
Q2 2024 |
Q2 2024 |
Interest Expense |
18K |
USD |
+323% |
Q2 2024 |
Q2 2024 |
Preferred Stock, Par or Stated Value Per Share |
0 |
USD/shares |
0% |
Q2 2024 |
Q2 2024 |